Invivyd, Inc. was recently added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, increasing its presence among publicly traded biotech peers. This twin index inclusion can broaden Invivyd’s exposure to institutional investors and passive funds that track biotech benchmarks, potentially reshaping how the company is viewed in the sector. Next, we’ll explore how Invivyd’s addition to major biotechnology indices could influence its existing investment...